ValiRx pleased with new joint ventures early progress - ValiRxs - TopicsExpress



          

ValiRx pleased with new joint ventures early progress - ValiRxs (LON:VAL) new joint venture, Valiseek, has made an encouraging start with its lung cancer treatment being well tolerated in early stage studies, the drug development company said today. Valiseek was set up in April to speed the progress of partner Tangent Reprofilings lung cancer treatment, now called VAL401, towards phase II trials. Key results from non-regulatory toxicology studies confirmed that the... ow.ly/2GJYmh
Posted on: Thu, 15 May 2014 07:27:57 +0000

Trending Topics



Recently Viewed Topics




© 2015